Specialty Chemicals M&A » By The Online Investor Staff, updated Tue., Apr. 30, 10:15 AM
Recent mergers and acquisitions in the Specialty Chemicals M&A category.
Slide #6. SI Group — Albemarle's antioxidant, ibuprofen and propofol businesses
Acquirer: |
SI Group |
Acquiree: |
Albemarle's antioxidant, ibuprofen and propofol businesses (NYSE:ALB) |
Details: |
Albemarle Corporation (NYSE: ALB), a leading manufacturer of highly-engineered specialty chemicals, announced today that it has signed a definitive agreement to sell certain assets to SI Group, a leading global developer and manufacturer of chemical intermediates, specialty resins, and solutions. Included in the transaction are Albemarle's antioxidants and FDA-regulated ibuprofen and propofol businesses and assets, with manufacturing sites in Orangeburg, South Carolina and Jinshan, China; and Albemarle's antioxidant product lines. Certain applications and technical support capabilities in Shanghai, China and Baton Rouge, Louisiana will also be included in the transaction. Terms of the transaction were not disclosed. |
Open the ALB Page at The Online Investor »
Company Name: |
Albemarle Corp. |
Stock buyback: |
ALB buyback |
Website: |
www.albemarle.com |
Sector: |
Specialty Chemicals |
Number of ETFs Holding ALB: |
104 |
Total Market Value Held by ETFs: |
$2.91B |
Total Market Capitalization: |
$13.50B |
% of Market Cap. Held by ETFs: |
21.58% |
|
Open the ALB Page at The Online Investor (in a new window) »
|
April 30, 2024 10:15 AM Eastern
Buy (3.03 out of 4)
33rd percentile
|
|